Baader Bank Aktiengesellschaft Makes New $497,000 Investment in Tenet Healthcare Corporation $THC

Baader Bank Aktiengesellschaft purchased a new position in shares of Tenet Healthcare Corporation (NYSE:THC) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 2,567 shares of the company’s stock, valued at approximately $497,000.

A number of other large investors have also recently bought and sold shares of THC. Eminence Capital LP acquired a new stake in Tenet Healthcare during the 3rd quarter worth about $225,263,000. Boston Partners grew its holdings in Tenet Healthcare by 38.8% during the 3rd quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after acquiring an additional 880,413 shares during the period. AQR Capital Management LLC grew its holdings in Tenet Healthcare by 62.3% during the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock worth $380,989,000 after acquiring an additional 720,160 shares during the period. Alliancebernstein L.P. grew its holdings in Tenet Healthcare by 375.7% during the 2nd quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock worth $139,085,000 after acquiring an additional 624,125 shares during the period. Finally, WCM Investment Management LLC boosted its position in shares of Tenet Healthcare by 244.4% during the 3rd quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock worth $102,657,000 after purchasing an additional 362,083 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, insider R. Scott Ramsey sold 8,017 shares of the stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $232.70, for a total value of $1,865,555.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Thomas W. Arnst sold 8,000 shares of the business’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $238.85, for a total transaction of $1,910,800.00. Following the transaction, the executive vice president owned 12 shares in the company, valued at approximately $2,866.20. This trade represents a 99.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 46,517 shares of company stock worth $10,943,111 over the last quarter. Insiders own 0.81% of the company’s stock.

Analyst Ratings Changes

THC has been the topic of a number of research analyst reports. Guggenheim cut their price objective on shares of Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Stephens cut their price objective on shares of Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating on the stock in a research report on Monday, May 4th. UBS Group increased their price objective on shares of Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Jefferies Financial Group increased their price objective on shares of Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. Finally, KeyCorp cut their price objective on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Nineteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $244.16.

Tenet Healthcare Price Performance

Shares of NYSE THC opened at $196.39 on Friday. Tenet Healthcare Corporation has a fifty-two week low of $146.60 and a fifty-two week high of $247.21. The stock has a market cap of $16.92 billion, a price-to-earnings ratio of 10.21, a PEG ratio of 1.32 and a beta of 1.30. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36. The firm’s 50-day simple moving average is $199.44 and its 200 day simple moving average is $203.75.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, beating the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business had revenue of $5.37 billion for the quarter, compared to analysts’ expectations of $5.39 billion. During the same quarter last year, the firm earned $4.36 EPS. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, research analysts anticipate that Tenet Healthcare Corporation will post 17.56 earnings per share for the current fiscal year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.